Adir Et Compagnie

Les Laboratoires Servier

Patrick Depreux

Pierre Renard

Daniel Lesieur

Gerard Adam

Said Yous

Daniel H Caignard

Beatrice Guardiola

Isabelle Lesieur

Philippe Delagrange

Beatrice Guardiola-Lemaitre

Daniel-Henri Caignard

Hamid Ait Mansour

Veronique Leclerc

Thierry Taverne

Bruno Pfeiffer

Marie-Claire Rettori

Caroline Bennejean

Jean Andrieux

Ange Mouithys-Mickalad

Eric Fourmaintraux

Francedillaois Lefoulon

G Erard Adam

Ousmane Diouf

Mark Millan

Marie-Claude Viaud

Adrian Newman-Tancredi

Jean Albert Boutin

G&eacute;rald Guillaumet

Luc Demuynck

Gérald Guillaumet

Nigel Levens

Carole Descamps-Francois

Raymond Houssin

B Eatrice Guardiola-Lemaitre

Pascal Carato

Catherine Dacquet

Habib Abdellaoui

Gwenael Cheve

Carlos Larraya

Geard Adam

Philippe Delagrance

Beatrice Guardiola Lemaitre

Ve'ronique Leclerc

Jean-Paul Bonte

Elodie Blanc-Delmas

Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same

Substituted dimeric compounds

Compound of formula (I): ##STR1## wherein: T represents alkylene,

Naphthalene compounds

A compound selected from those of formula (I): ##STR1## in which A, Y, R.sup.1, R.sup.2 and R.sup.3 are as defined in the Specification, and pharmaceutical compositions containing the same, which are useful for treating a mammal afflicted with a disorder of the melatoninergic system.

Tricyclic urea compounds

This invention relates to benzofuran/pyran derivatives of a new tricyclic amide compound, their composition and method of use for treating disorders of the melatoninergic system.

Tricyclic amide compounds

A compound of general formula (I): ##STR1## where A, X, R.sub.1, Y, n and Ar are defined in the description. Medicinal products containing the same are useful as D.sub.4 receptor Ligands.

Heterocyclic aminomethyl compounds

A compound selected from those of formula (I): ##STR1## in which A, Y, R.sup.1, R.sup.2 and R.sup.3 are as defined in the description, and a medicinal product containing the same useful for treating a mammal afflicted with a disorder of the melatoninergic system.

The invention relates to a compounds selected from these of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and a medicinal product containing the same useful for treating a melatoninergic disorder.

Alkylated (hetero) cyclic compounds

The invention relates to a compound selected from those of formula (I): ##STR1## in which A, R.sub.1, R'.sub.1, R.sub.2, R.sub.3 and n are as defined in the description, and medicinal product containing the same useful for treating a mammal afflicted with a disorder of the melatoninergic system.

Aryl(alkyl)propylamides

The invention relates to a compound selected from those of formula (I): ##STR1## in which A, B, X and R.sub.1 are as defined in the description, and medicinal product containing the same useful for treating a disorder of the melatoninergic system.

Arylalkyl(thio)carboxamides

The invention relates to a compound selected from those of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and Medicinal product containing the same useful for treating a disorder of the melatoninergic system.

Method of treating disorders of the melatoninergic system and a certain

The invention relates to a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, X and n are as defined in the description, the optical isomers thereof, and the addition salts thereof with a pharmaceutically acceptable acid or base and medicinal product containing the same, useful for treating a mammal afflicted with a pathology associated with the sigma receptors.

Aminoalkyl benzoxazolinones and benzothiazolinones

Growing community of inventors

Armentieres, France

Patrick Depreux